Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers. The generic pharmaceutical industry operates ...

More importantly, there are lots of other types of vaccines that are key growth drivers for some pharmaceutical companies. Here's what you need to know about investing in the top vaccine stocks ...

JD.com, Eli Lilly and Company, Abbott Laboratories, Veeva Systems, and Johnson & Johnson are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool.

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) stands against ...

HC Wainwright currently has a “Buy” rating and a $50.00 target price on the stock. The consensus estimate for Collegium Pharmaceutical’s current full-year earnings is $5.62 per share.

WASHINGTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical company ...

Explore Biomarin Pharmaceutical stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BMRN. BioMarin exceeded Q4 earnings expectations, raised 2025 guidance ...

Companies worth $10 billion or more are generally described as "large-cap stocks," West Pharmaceutical fits right into that category, with its market cap exceeding this threshold, reflecting its ...